Versigent PLC (NYSE:VGNT): Analyzing Its Electrical Power Systems, EV Charging, and Financial Outlook

• Versigent PLC (NYSE:VGNT) specializes in electrical power systems and EV charging infrastructure, serving automotive, commercial, and energy sectors.
• The company maintains strong customer relationships, with 75% of revenue from full-service programs involving early design collaboration with original equipment manufacturers (OEMs).
• Management targets an adjusted EBITDA margin of about 12% by 2028 and cumulative free cash flow of approximately $1 billion between 2026 and 2028, leading to a "buy" rating from analysts.

Versigent PLC (NYSE:VGNT) is a Swiss company that engineers and distributes electrical power systems. Operating independently since 2026, Versigent provides solutions for low- and high-voltage needs. Its products include power distribution frameworks and EV charging infrastructure for the automotive, commercial vehicle, and energy grid sectors.

The consensus price target for Versigent has seen minor changes, moving from $47.79 last year to $49 last month. Following its Q1 2026 earnings call, an analyst at UBS Group AG (NYSE: UBS) set a more recent price target of $43 for the stock. This suggests a specific adjustment based on the latest company performance data.

A key strength for Versigent is its customer relationships. Approximately 75% of the company's revenue comes from full-service programs. These programs involve early design collaboration with original equipment manufacturers (OEMs), like car makers. This approach helps build strong, embedded partnerships with its clients.

Management provides a clear financial outlook, targeting an adjusted EBITDA margin of about 12% by 2028. EBITDA margin is a measure of a company's operational profitability. Versigent also aims for a cumulative free cash flow of approximately $1 billion between 2026 and 2028, showing its ability to generate cash after expenses.

As highlighted by UBS, the company has received a "buy" rating from one of its analysts. The analyst believes the market currently undervalues Versigent's scale and potential for profit growth. This positive view is based on the company hitting its financial targets and leveraging its strong OEM relationships.